BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 8652835)

  • 21. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.
    Bose S; Deininger M; Gora-Tybor J; Goldman JM; Melo JV
    Blood; 1998 Nov; 92(9):3362-7. PubMed ID: 9787174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects.
    Gorbenko AS; Stolyar MA; Vasiliev EV; Mikhalev MA; Bakhtina VI; Olkhovik TI; Mochalova EE; Orlova KE; Olkhovskiy IA
    Klin Lab Diagn; 2021 Sep; 66(9):571-576. PubMed ID: 34543537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway.
    Yuanxin Y; Yanhong Z; Qin Z; Sishi T; Yang D; Yi Z; Minjin W; Juan Z; Xiaojun L; Lanlan W; Binwu Y
    Leuk Res; 2019 Apr; 79():6-16. PubMed ID: 30784762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
    Adnan-Awad S; Kim D; Hohtari H; Javarappa KK; Brandstoetter T; Mayer I; Potdar S; Heckman CA; Kytölä S; Porkka K; Doma E; Sexl V; Kankainen M; Mustjoki S
    Leukemia; 2021 Jul; 35(7):1964-1975. PubMed ID: 33168949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of alternative splicing in bcr-abl mRNA in chronic myeloid leukemia cell lines.
    Hermans A; Selleri L; Gow J; Grosveld GC
    Blood; 1988 Dec; 72(6):2066-9. PubMed ID: 2848601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript.
    Kunieda Y; Okabe M; Kurosawa M; Itaya T; Kakinuma M; Miyazaki T
    Ann Hematol; 1994 Oct; 69(4):189-93. PubMed ID: 7948305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
    Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H
    Blood; 2000 Feb; 95(4):1144-50. PubMed ID: 10666183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.
    Schmidt M; Nagel S; Proba J; Thiede C; Ritter M; Waring JF; Rosenbauer F; Huhn D; Wittig B; Horak I; Neubauer A
    Blood; 1998 Jan; 91(1):22-9. PubMed ID: 9414265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises.
    Ponzetto C; Guerrasio A; Rosso C; Avanzi G; Tassinari A; Zaccaria A; LoCoco F; Foa R; Basso G; Abate ML
    Br J Haematol; 1990 Sep; 76(1):39-44. PubMed ID: 2223647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
    J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
    Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F; van Rhee F; Goldman JM; Cross NC
    Blood; 1996 May; 87(10):4473-8. PubMed ID: 8639810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.
    Kantarjian HM; Talpaz M; Dhingra K; Estey E; Keating MJ; Ku S; Trujillo J; Huh Y; Stass S; Kurzrock R
    Blood; 1991 Nov; 78(9):2411-8. PubMed ID: 1932753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
    Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.
    Tanaka M; Yamazaki Y; Hattori M; Tsushita K; Utsumi M; Yoshida S
    Leuk Res; 1996 Jul; 20(7):575-80. PubMed ID: 8795691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia.
    Morgan GJ; Hernandez A; Chan LC; Hughes T; Martiat P; Wiedemann LM
    Br J Haematol; 1990 Sep; 76(1):33-8. PubMed ID: 2223646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
    Diamond J; Goldman JM; Melo JV
    Blood; 1995 Apr; 85(8):2171-5. PubMed ID: 7718887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction.
    Dobrovic A; Trainor KJ; Morley AA
    Blood; 1988 Dec; 72(6):2063-5. PubMed ID: 3143430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.